We are very happy to share that the Ministry of Health of Luxembourg has confirmed that starting on 1/1/2024, all newborns born in the country will be screened for SMA.
 

https://sante.public.lu/fr/agenda/2023/11/formation-atrophie-musculaire-spinale.html

Currently, newborns there are screened only for five disorders. Spinal Muscular Atrophy will be the sixth one.

The drug Spinraza, used to treat the neurodegenerative disease SMA, has been approved for the treatment of adults in October 2023. So far, it has only been approved for use by children. For more information please click here.

Today we celebrate International Neonatal Screening Day! 😊

Check out the latest publication on #newbornscreening issued by RARE Revolution Magazine. Our Steering Committee member Kacper Rucinski, co-founder of SMA Foundation Poland, speaks about the challenges of ensuring Europe-wide newborn screening for SMA.